Literature DB >> 7382493

Simultaneous radioimmunoassay of progestins, androgens and estrogens in rat testis.

A Bélanger, S Caron, V Picard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7382493     DOI： 10.1016/0022-4731(80)90190-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN： 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  12 in total

1.  Effects of Gn-RH on blood serum hormone concentrations, ovulation rates and embryo production in lactating cows treated with PMSG.

Authors:  P Guay; M Bedoya
Journal:  Can J Comp Med       Date:  1981-10

2.  Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.

Authors:  F Labrie; A Dupont; A Bélanger; J Emond; G Monfette
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

3.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate.

Authors:  S Li; M Lepage; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Preparation and characterization of rabbit myometrial cells in primary culture: influence of estradiol and progesterone treatment.

Authors:  A P Boulet; M A Fortier
Journal:  In Vitro Cell Dev Biol       Date:  1987-02

6.  Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.

Authors:  F Labrie; S Li; A Bélanger; J Côté; Y Mérand; M Lepage
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

7.  Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.

Authors:  P G Spinola; B Marchetti; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

8.  Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.

Authors:  S Li; X Yan; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

9.  Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.

Authors:  S Dauvois; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

10.  Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.

Authors:  G Tolis; A Mehta; A M Comaru-Schally; A V Schally
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.